Sign In
Buy KALA
$3.54
-0.0700 (-1.94%)
At Close: Jun 22, 2026
Kala Pharma: Rare Eye Disease Biotech Lottery Ticket Based On Stem Cell Platform
07:12am, Thursday, 19'th Jan 2023
FDA Accepted IND Filing for the company to initiate a phase 2b study using KPI-012 for the treatment of patients with the persistent corneal epithelial defect. The phase 2b study, using KPI-012 for th
Kala Pharmaceuticals Up 400% In The Past Month, What's Next?
08:51am, Wednesday, 11'th Jan 2023
Kala pharmaceuticals underwent a massive rally over the past few days, and by all indications, the stock price is now headed toward a bottom.
Kala Pharmaceuticals stock up 750% in 3 days after upbeat FDA news on PCED treatment
12:02pm, Friday, 30'th Dec 2022
Shares of Kala Pharmaceuticals Inc. KALA, +39.53% have rocketed higher in for three-straight sessions, toward a more-than 8-fold gain, since the biopharmaceutical company announced positive news regar
Kala Pharmaceuticals Stock Continues To Soar: What's Going On? - Kala Pharmaceuticals (NASDAQ:KALA)
08:30am, Thursday, 29'th Dec 2022
Kala Pharmaceuticals Inc KALA shares are trading higher Thursday. The stock appears to be moving on continued momentum after the company on Wednesday announced FDA acceptance of an investigational
Kala Pharmaceuticals Stock Surges on FDA Update
01:18pm, Wednesday, 28'th Dec 2022
Kala Pharmaceuticals Inc (NASDAQ:KALA) is bucking the broader-market trend this afternoon, up 283.2% lead to trade at $15.02.
Why Is Kala Pharmaceuticals (KALA) Stock Soaring 240%?
01:14pm, Wednesday, 28'th Dec 2022
Amid another soft performance for the benchmark equities index, rare-eye disease specialist Kala Pharmaceuticals (NASDAQ: KALA ) lit up the overcast sky with a stunning triple-digit performance. Yeste
Kala Pharmaceuticals (KALA) Up as FDA Accepts IND for KPI-012
12:21pm, Wednesday, 28'th Dec 2022
The FDA accepts Kala Pharmaceuticals' (KALA) investigational new drug application for pipeline candidate KPI-012 for treating persistent corneal epithelial defect. Stock up.
Kala Pharmaceuticals stock rockets after FDA accepts IND application for PCED treatment
06:48am, Wednesday, 28'th Dec 2022
Shares of Kala Pharmaceuticals Inc. KALA, +1.03% shot up 45.7% in premarket trading Wednesday, after the biopharmaceutical company said the Food and Drug Administration accepted its investigational ne
Here's Why Kala Pharma (KALA) Looks Ripe for Bottom Fishing
11:17am, Wednesday, 07'th Dec 2022
Kala Pharma (KALA) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wa
Kala Pharmaceuticals to Present at H.C. Wainwright 24th Annual Global Investment Conference
08:00am, Tuesday, 06'th Sep 2022
ARLINGTON, Mass., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization o
Why Nuwellis Surged Over 121%; Here Are 66 Biggest Movers From Yesterday
09:19am, Thursday, 01'st Sep 2022 Benzinga
Gainers
Nuwellis, Inc. (NASDAQ: NUWE) shares climbed 121.3% to close at $1.46 on Wednesday after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ul
Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session
04:47pm, Wednesday, 31'st Aug 2022 Benzinga
Gainers
Nuwellis, Inc. (NASDAQ: NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-r
Why Cepton Is Trading Higher By 19%; Here Are 28 Stocks Moving Premarket
11:14am, Wednesday, 31'st Aug 2022 Benzinga
Gainers
Software Acquisition Group Inc. III (NASDAQ: NOGN) shares rose 80.1% to $6.04 in pre-market trading after dropping over 65% on Tuesday.
Kala Pharmaceuticals, Inc. (NASDAQ: KALA) shares rose 3
Why AMC Entertainment Is Trading Lower By 33%; Here Are 31 Stocks Moving Premarket
11:13am, Monday, 22'nd Aug 2022 Benzinga
Gainers
Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares rose 48.5% to $0.56 in pre-market trading. Kiromic Biopharma said the company has determined not to pursue, at this time, the contemplated publi
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
08:01pm, Friday, 19'th Aug 2022 GlobeNewswire Inc.
ARLINGTON, Mass., Aug. 19, 2022 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock options to new employees as an inducement a
